http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2727629-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
filingDate 1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37d2979a6b7193cb8539b1d23b728a2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f330772016d5e628e66e49646550c017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87957ad3970e4cb3ccee39ac302a580f
publicationDate 1996-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2727629-A1
titleOfInvention OSTEOPOROSIS TREATMENT CYCLE KIT
abstract The invention relates to a kit for use in a therapeutic cycle based on the sequential administration of tiludronic acid or one of its salts and / or solvates and calcium for 28 to 31 days, for treatment and / or prevention. osteoporosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1790347-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20041013-B1
priorityDate 1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9400129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0210728-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0582515-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0381296-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72941702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407563347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450210028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452691591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152774259

Total number of triples: 42.